Research output per year
Research output per year
Personal profile
Biography
As the Principal Investigator of the Ocular Therapeutics Research Group (OTRG), within the PMBRC, and the coordinator of the ORBITAL-ITN network, my research is focused primarily on the development and production of novel therapeutics to treat various chronic and acute diseases of the eye. This is achieved by developing new nano- and micro-formulations, investigating novel therapeutics and designing innovative drug delivery platforms to improve patient outcomes and quality of life issues for a range of ophthalmic conditions. I am also interested in applying these technologies to other pressing societal challenges that include Covid-19 and antimicrobial resistance.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Laurence Fitzhenry is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Design of liposomal nanocarriers with a potential for combined dexamethasone and bevacizumab delivery to the eye
Farooq, U., O'Reilly, N., Ahmed, Z., Gasco, P., Singh, T. R. R., Behl, G., Fitzhenry, L. & McLoughlin, P., 01 Apr 2024, In: International Journal of Pharmaceutics. 654, p. 123958 123958.Research output: Contribution to journal › Article › peer-review
Open Access -
Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells
Dandamudi, M., Fitzhenry, L., Rani, S., McLoughlin, P., Coffey, L. V. & Behl, G., 19 Apr 2024, In: Frontiers in Drug Delivery. 4Research output: Contribution to journal › Article › peer-review
Open Access -
An evaluation of hyaluronic acid and poly(L-lysine) polyelectrolyte complexes for intraocular nicotinamide adenine dinucleotide (NAD+) delivery.
Casey-Power, S., Ryan, R., Behl, G., Mc Loughlin, P., Fitzhenry, L., Byrne, M. E. & Vardar, C., 25 Apr 2023.Research output: Contribution to conference › Poster › peer-review
-
How patient/public involvement impacts the research journey – an overview of the visual impairment research field
Ames, T., Matthews, E., Reynolds, A., Fitzhenry, L., Logan, A., Gooney, M. & Filipe, H. P., 05 Sep 2023, In: Open Research Europe.Research output: Contribution to journal › Article › peer-review
-
Immune System, Inflammation and Autoantigens in Wet Age-Related Macular Degeneration: Pathological Significance and Therapeutic Importance
Manikandan, S. K., Logan, A., Cerrada-Gimenez, M., Fitzhenry, L., Coffey, L., Kaja, S. & Rani, S., Dec 2023, In: Life. 13, 12, 2236.Research output: Contribution to journal › Review article › peer-review
Open Access
Press/Media
-
Findings from Waterford Advance Knowledge in Age-Related Macular Degeneration (Investigation of novel combination therapy for age-related macular degeneration on ARPE-19 cells)
Rani, S., Coffey, L. V., Fitzhenry, L., Behl, G., McLoughlin, P. & Dandamudi, M.
02/05/2024
1 item of Media coverage
Press/Media